Welcome

Mark your calendar now and plan to attend the Symposium on Cardiovascular
Regenerative Medicine on October 14-15, 2009. Register Online

The National Heart, Lung, and Blood Institute's third Symposium on Cardiovascular Regenerative Medicine will focus on stem cell therapies for the potential treatment of cardiovascular disease, highlighting both basic research and clinical applications. A broad cross-section of experts in the field, including researchers involved in the basic science of stem cell biology, as well as specialist cardiovascular physicians, will discuss the emerging science, preclinical animal models, and the translation of these advances to the clinic.

Download a .PDF of the the Symposium poster.


Confirmed Speakers:

  • Irwin D. Bernstein, M.D., Fred Hutchinson Cancer Research Center
  • Helen M. Blau, Ph.D., Stanford University School of Medicine
  • Richard Cannon, M.D., National Heart, Lung, and Blood Institute, NIH
  • Kenneth R. Chien, M.D., Ph.D., Massachusetts General Hospital/Harvard Medical School/Harvard Stem Cell Institute
  • George Q. Daley, M.D., Ph.D., Harvard Medical School/Children’s Hospital Boston
  • Hal Dietz, M.D., Johns Hopkins University School of Medicine
  • Sheng Ding, Ph.D., The Scripps Research Institute
  • Stephen G. Ellis, M.D., The Cleveland Clinic
  • Jonathan A. Epstein, M.D., Hospital of the University of Pennsylvania
  • Martin Friedlander, M.D., Ph.D., The Scripps Research Institute and the Scripps Clinic
  • Alan D. Friedman, M.D., Johns Hopkins University School of Medicine
  • Jonas Frisén, M.D., Ph.D., Karolinska Institute (Sweden)
  • Valentin Fuster, M.D., Mount Sinai School of Medicine
  • Joshua M. Hare, M.D., F.A.C.C., F.A.H.A., Miller School of Medicine, University of Miami
  • Luisa Iruela-Arispe, Ph.D., University of California, Los Angeles
  • Juan Carlos Izpisúa Belmonte, Ph.D., Center of Regenerative Medicine, Barcelona (Spain)
  • Raghu Kalluri, M.D., Ph.D., Harvard University/Beth Israel Deaconess Medical Center
  • Gordon Keller, Ph.D., Ontario Cancer Institute (Canada)
  • Mark Krasnow, M.D., Ph.D., Stanford University School of Medicine
  • Bernhard Kühn, M.D., Harvard Medical School/Children’s Hospital Boston
  • Ronald D.G. McKay, Ph.D., National Institute of Neurological Disorders and Stroke, NIH
  • Christine Mummery, Ph.D., Leiden University Medical Center (The Netherlands)
  • Charles E. Murry, M.D., Ph.D., University of Washington Medical Center
  • Elizabeth G. Nabel, M.D., National Heart, Lung, and Blood Institute, NIH
  • Kenneth D. Poss, Ph.D., Duke University Medical Center
  • William T. Pu, M.D., Children’s Hospital Boston
  • Robert D. Simari, M.D., Mayo Clinic
  • Bruce M. Spiegelman, Ph.D., Harvard Medical School/Dana-Farber Cancer Institute
  • Amy Wagers, Ph.D., Harvard Medical School
  • Brant M. Weinstein, Ph.D., National Institute of Child Health and Human Development, NIH
  • Sean M. Wu, M.D., Ph.D., Harvard Medical School/Massachusetts General Hospital
  • Deborah L. Yelon, Ph.D., University of California, San Diego

Organizing Committee:

  • Elizabeth G. Nabel, M.D., Director, NHLBI
  • Manfred Boehm, M.D., Translational Medicine Branch, Division of Intramural
    Research, NHLBI
  • Denis B. Buxton, Ph.D., Basic and Early Translational Research Branch, Division of Cardiovascular Sciences, NHLBI
  • Kenneth R. Chien, M.D., Ph.D., Massachusetts General Hospital/Harvard Medical School/Harvard Stem Cell Institute
  • Stephen G. Ellis, M.D., The Cleveland Clinic
  • Jonathan A. Epstein, M.D., Hospital of the University of Pennsylvania
  • Martin Friedlander, M.D., Ph.D., The Scripps Research Institute and the
    Scripps Clinic
  • Joshua M. Hare, M.D., Miller School of Medicine - University of Miami
  • Jason C. Kovacic, M.B.B.S., Ph.D., Mount Sinai School of Medicine
  • Yosuke Mukoyama, Ph.D., Laboratory of Developmental Biology, Division
    of Intramural Research, NHLBI
  • Charles E. Murry, M.D., Ph.D., University of Washington Medical Center
  • John W. Thomas, Ph.D., Division of Blood Diseases and Resources, NHLBI
  • Brant M. Weinstein, Ph.D., National Institute of Child Health and Human Development, NIH




symposium goals


  - To provide an overview of the
    NHLBI roadmap for cardio-
    vascular stem cell research
    going forward.

  - To relate novel insights from
    embryonic cardiovascular
    development to our understand-
    ing of adult cardiovascular
    stem cells.

 - To review the recent break-
    through discovery of induced-
    pluripotent stem cells (iPS-cells),
    and how they might be harness-
    ed for therapeutic applications.

 - To discuss the emerging and
    inter-related field of epithelial
    to mesenchymal transition,
    and the relevance of this to
    cardiovascular and stem cell
    biology.

 - To emphasize recent discover-
    ies that will facilitate the trans-
    lation of this knowledge from
    bench to bedside.
Twitter iconTwitterExternal link Disclaimer         Facebook iconFacebookimage of external link icon         YouTube iconYouTubeimage of external link icon         Google+ iconGoogle+image of external link icon